Arcus Biosciences (RCUS) Interest Expenses (2023 - 2026)

Arcus Biosciences' Interest Expenses history runs 4 years deep, the most recent figure standing at $3.0 million for Q1 2026.

• In Q1 2026, Interest Expenses rose 200.0% year-over-year to $3.0 million; the TTM figure through Mar 2026 stood at $10.0 million (up 150.0% YoY), while the FY2025 annual figure was $8.0 million, up 100.0% from the prior year.
• Interest Expenses was $3.0 million for Q1 2026 at Arcus Biosciences, up from $2.0 million in the prior quarter.
• In the past five years, Interest Expenses ranged from a high of $3.0 million in Q3 2025 to a low of $1.0 million in Q3 2023.
• Historically, Interest Expenses has averaged $1.8 million across 4 years, with a median of $2.0 million in 2024.
• The sharpest annual moves came in 2024 and 2025: Interest Expenses changed 0.0% in 2024, then surged 200.0% in 2025.
• A 4-year view of Interest Expenses shows it stood at $1.0 million in 2023, then soared by 100.0% to $2.0 million in 2024, then changed by 0.0% to $2.0 million in 2025, then surged by 50.0% to $3.0 million in 2026.
• The last three Interest Expenses figures came in at $3.0 million (Q1 2026), $2.0 million (Q4 2025), and $3.0 million (Q3 2025), per Business Quant data.